Phaseline

Companies › Amicus Therapeutics

Amicus Therapeutics: clinical trials, targets and expected readouts

3 active drug programs in 6 registered trials: 6 Phase 3; Metabolic and endocrine, Genitourinary; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Migalastat
Alpha-galactosidase A stabiliser
GLAPhase 3Fabry DiseaseDec 2026
Cipaglucosidase Alfa (ATB200)
Acid alpha-glucosidase (GAA) enzyme replacement therapy
GAAPhase 3Pompe Disease (Late-onset); Glycogen Storage Disease Type II Infantile OnsetMar 2027
Miglustat (AT2221)
Ceramide glucosyltransferase inhibitor
UGCGPhase 3Pompe Disease (Late-onset); Glycogen Storage Disease Type II Infantile OnsetMar 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT04020055MigalastatPhase 3Fabry DiseaseGenitourinaryDec 2026
NCT03911505Cipaglucosidase Alfa (ATB200)Phase 3Pompe Disease (Late-onset)Metabolic and endocrineMar 2027
NCT03911505Miglustat (AT2221)Phase 3Pompe Disease (Late-onset)Metabolic and endocrineMar 2027
NCT04808505Cipaglucosidase Alfa (ATB200)Phase 3Glycogen Storage Disease Type II Infantile OnsetMetabolic and endocrineJul 2027
NCT04808505Miglustat (AT2221)Phase 3Glycogen Storage Disease Type II Infantile OnsetMetabolic and endocrineJul 2027
NCT06904261MigalastatPhase 3Fabry DiseaseMetabolic and endocrineDec 2027

Targets

GAA (1) UGCG (1) GLA (1)

Companies with the same targets

Sanofi Astellas GeneCradle Spark Therapeutics AskBio Azafaros Idorsia Pharmaceuticals UniQure Biopharma Chiesi Farmaceutici Takeda

Companies built like this

Beijing Dongfang Biotech Azafaros The United Bio-Technology (Hengqin) Actimed Therapeutics Fresenius Kabi

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.